PR Newswire (Tue, 4:05PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
167 people get RGLS articles and Market Currents by email alert.
Get email alerts on RGLS »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
PR Newswire (May 7, 2013)
-
-
PR Newswire (Apr 24, 2013)
-
-
-
-
-
-
-
-
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012
-
-
-
IPO Preview: Regulus TherapeuticsIPOdesktop • Tue, Oct 2, 2012
-
8 IPOs Scheduled For The Week Of October 1IPOdesktop • Tue, Oct 2, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
IPO Preview: Intercept PharmaceuticalsIPOdesktop • Wed, Oct 10, 2012
-
-
8 IPOs Scheduled For The Week Of October 1IPOdesktop • Tue, Oct 2, 2012
-
-
-
PR Newswire (Tue, 4:05PM)
-
PR Newswire (May 7, 2013)
-
PR Newswire (Apr 24, 2013)
-
at MarketWatch.com (Oct 4, 2012)
RGLS vs. ETF Alternatives
Company Description
We are a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases. We were formed in 2007 when Alnylam Pharmaceuticals, Inc., or Alnylam, and Isis Pharmaceuticals, Inc., or Isis, contributed significant... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, May 15, 6:42 AM Regulus Therapeutics (RGLS): Q1 EPS of -$0.20 misses by $0.09. Revenue of $3.2M beats by $0.05M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, February 20, 7:25 PM Regulus Therapeutics (RGLS): Q4 EPS of -$0.22 misses by $0.15. Revenue of $3.2M misses by $0.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
-
Friday, January 11, 12:45 PM
Midday top 10 gainers: UPIP +31%. KGJI +20%. INFY +17%. DNDN +15%. REDF +14%. FLML +14%. BBY +12%. SIFY +11%. ICAD +10%. BCRX +10%.
Midday top 10 Losers: NEWL -29%. ARQL -15%. YOD -15%. PDEX -12%. BV -11%. RGLS -10%. FARO -9%. CENX -9%. MY -9%. STXS -9%. Comment! [On the Move] -
Thursday, December 27, 2012, 12:45 PM
Midday top 10 gainers: BCDS +92%. FSGI +19%. ENPH +15%. RGLS +11%. MNGA +10%. CLNT +9%. OSBC +9%. DECK +8%. BLIN +8%. PZE +7%.
Midday top 10 Losers: SSE -16%. SPMD -14%. GNI -12%. CIG -12%. CHC -14%. SARA -9%. TOWR -9%. TELK -9%. DQ -8%. AMRS -8%. Comment! [On the Move] -
Monday, December 24, 2012, 11:15 AM
Midday top 10 gainers: ATV +34%. CT +18%. ALIM +12%. CLSN +12%. EJ +11%. EDAP +11%. GSS +11%. RGLS +10%. AVEO +10%. EGLE +10%.
Top 10 Losers: MHH -30%. TLAB -27%. ALXA -14%. XRTX -12%. AMPL -11%. CIG -10%. SVA -9%. ISS -9%. MITL -8%. RPTP -8%. 1 Comment [On the Move] - Monday, November 19, 2012, 4:20 PM Regulus Therapeutics Inc. (RGLS): Q3 EPS of -$15.98 beats by $1.02. (PR) Comment! [Earnings, Healthcare]
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.